Development of an bioactive preadipocyte loaded fibroin biohybrid for the augmentation of soft tissue defects.

开发一种负载丝心蛋白的生物活性前脂肪细胞生物杂交体,用于增强软组织缺陷。

基本信息

项目摘要

This proposal originated at the DFG Nachwuchsakademie Zahnmedizin 2010 in Ulm and represents the second stage of the Nachwuchsakademie program.Defects of subcutaneous adipose tissue in the facial area with a loss of the isolating layer to the deeper laying structures cannot be reconstructed adequately without the use of suitable soft tissue transplants. Nowadays, autologous adipose tissue obtained by liposuction is commonly used, even though it has known shortcomings: the adipose cells are fully differentiated or damaged by the removal technique and are therefore prone to ischemic damage. The transplants shrink and harden or are even lost completely over time. Neovascularisation and nutritive supply are crucial factors for the survival of the transplanted adipose cells. The proposed project aims to develop an alternative to these conventional techniques by utilizing a novel scaffold material consisting of fibroin that presents the growth factors vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF-2). These growth factors promote the differentiation of adipocytes and vascularization of the transplant. The use of adipose tissue precursor cells (preadipocytes), which are capable of cell division, is advantageous to the use of differentiated adipocytes, mainly due to their higher tolerance for ischaemia. It is planned to construct specifically designed, bioactive three-dimensional scaffolds consisting of fibroin, that will be seeded with autologous preadipocytes and examined regarding their applicability as transplants. Fibroin, a silk protein, is a well-studied and validated biomaterial, that does not cause foreign body reactions or wound healing disorders. For the evaluation of fibroin as a carrier material for preadipocytes, scaffold materials in different three-dimensional structures and with different presentation densities of VEGF and FGF-2 are seeded with human preadipocytes. Subsequently, the adipogenic differentiation is monitored for 21 days by determining the expression levels of specific markers for adipogenic differentiation (PPAR-gamma, Glut4, FABP4, ACS, GPDH) on the transcriptional level (real time PCR) as well as on the protein level (ELISA). Successful differentiation will be verified in functional enzymatic and metabolic assays (GPDH activity, lipolysis and glucose-uptake assay) as well as immunohistologically (PPAR-gamma, Glut4, FABP4, ACS, GDPH, vWF, CD31) and morphologically (Oil-Red-O-staining). If differentiated adipose tissue transplants are successfully generated, an in vivo evaluation of the transplants in a follow-up project is planned.
这项建议起源于2010年在乌尔姆举行的DFG Nachwuchsakademie Zahnmedizin,代表了Nachwuchsakademie项目的第二阶段。面部区域皮下脂肪组织缺损伴隔离层向深层结构的缺失,如果不使用合适的软组织移植物,则无法充分重建。如今,通常使用通过吸脂获得的自体脂肪组织,即使它具有已知的缺点:脂肪细胞被完全分化或被去除技术损坏,因此易于缺血性损伤。移植物会随着时间的推移而收缩和硬化,甚至完全消失。新血管形成和营养供应是移植脂肪细胞存活的关键因素。拟议的项目旨在通过利用由丝心蛋白组成的新型支架材料开发这些常规技术的替代品,该丝心蛋白呈现生长因子血管内皮生长因子(VEGF)和成纤维细胞生长因子2(FGF-2)。这些生长因子促进脂肪细胞的分化和移植物的血管化。使用能够进行细胞分裂的脂肪组织前体细胞(前脂肪细胞)对于使用分化的脂肪细胞是有利的,这主要是由于它们对局部缺血具有更高的耐受性。计划构建专门设计的由丝素蛋白组成的生物活性三维支架,将其与自体前脂肪细胞一起接种,并检查其作为移植物的适用性。丝素蛋白是一种经过充分研究和验证的生物材料,不会引起异物反应或伤口愈合障碍。为了评价丝心蛋白作为前脂肪细胞的载体材料,将具有不同三维结构和具有不同VEGF和FGF-2呈递密度的支架材料与人前脂肪细胞接种。随后,通过在转录水平(真实的时间PCR)以及在蛋白质水平(ELISA)上测定脂肪形成分化的特异性标志物(PPAR-gamma、Glut 4、FABP 4、ACS、GPDH)的表达水平来监测脂肪形成分化21天。将在功能性酶和代谢试验(GPDH活性、脂解和葡萄糖摄取试验)以及免疫组织学(PPAR-gamma、Glut 4、FABP 4、ACS、GDPH、vWF、CD 31)和形态学(油红-O染色)中验证成功分化。如果分化的脂肪组织移植成功产生,在后续项目的移植体内评价计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr. Henning Hanken其他文献

Dr. Henning Hanken的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

中药复方“芍药甘草汤”活性成分的单克隆抗体制备及剔除分析法的建立
  • 批准号:
    30572316
  • 批准年份:
    2005
  • 资助金额:
    28.0 万元
  • 项目类别:
    面上项目
新功能肽Aglycin降低高血糖的机理和药理研究
  • 批准号:
    30470823
  • 批准年份:
    2004
  • 资助金额:
    30.0 万元
  • 项目类别:
    面上项目

相似海外基金

I-Corps: Translation Potential of Cellulose-Nanofiber-Based Surface Agents for Enhancing Bioactive Filtration Efficiency
I-Corps:纤维素纳米纤维基表面剂在提高生物活性过滤效率方面的转化潜力
  • 批准号:
    2401619
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Bioactive fragments of the extracellular matrix orchestrate lung epithelial cell repair.
细胞外基质的生物活性片段协调肺上皮细胞修复。
  • 批准号:
    BB/Y004183/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Atomic-Scale Engineering of Bioactive Organic Molecules on Surfaces
表面生物活性有机分子的原子尺度工程
  • 批准号:
    DP240100464
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Bioactive Effective Surface For Transport Network (BEST Network)
传输网络的生物活性有效表面(BEST网络)
  • 批准号:
    EP/X03576X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
EBioAct: Environmentally sustainable production of bioactive triterpenes
EBioAct:生物活性三萜的环境可持续生产
  • 批准号:
    BB/Y007751/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Mining the chemodiversity of the genus Myrica to reveal bioactive molecules for their medicinal uses
挖掘杨梅属的化学多样性,揭示其药用生物活性分子
  • 批准号:
    2880591
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
Biology the initiator: Harnessing Reactive Oxygen Species for Biocompatible Polymerization
生物学引发者:利用活性氧进行生物相容性聚合
  • 批准号:
    10667740
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Accessing and Expanding Natural Products Chemical Diversity by Big-data Analysis and Biosynthetic Investigation
通过大数据分析和生物合成研究获取和扩大天然产物化学多样性
  • 批准号:
    10714466
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Unlocking New Chemistries in Extant Enzymes for Synthesizing Bioactive Molecules
解锁现有酶中用于合成生物活性分子的新化学成分
  • 批准号:
    10784165
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了